ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France (Podcast Pearls)

PDF
Experts from France provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Released: December 09, 2020

Expiration: December 08, 2021

No longer available for credit.

Share

Faculty

Marine Gross-Goupil

Marine Gross-Goupil, MD, PhD

Medical Oncologist
Department of Medical Oncology
University Hospital
Bordeaux, France

Alain Ravaud

Alain Ravaud, MD, PhD

Professor of Medical Oncology
Bordeaux University
Head of Medical Oncology
Department of Medical Oncology
Bordeaux University Hospital,
Bordeaux, France

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Marine Gross-Goupil, MD, PhD

Medical Oncologist
Department of Medical Oncology
University Hospital
Bordeaux, France

Alain Ravaud, MD, PhD

Professor of Medical Oncology
Bordeaux University
Head of Medical Oncology
Department of Medical Oncology
Bordeaux University Hospital,
Bordeaux, France